Replimune Group Inc
Biotechnology
Healthcare
REPL
80.56 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.29
52 week high
14.93
high
4.39
52 week low
0.00
previous Close
3.27
P/E ratio
market cap
705 M
div yield
0
net incoming
-74.13 M
-11.74 %
net profit margin
-7413000000.00 %
0.00 %
operating incoming
-79.33 M
-20.15 %
net change in cash
-61.12 M
-204.05 %
cash on hand
484 M
180.88 %
cost of revenue
-736.00 K
0.00 %
top